191 related articles for article (PubMed ID: 29180527)
21. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.
Girard D; Finegan SM; Dunne MW; Lame ME
J Antimicrob Chemother; 2005 Aug; 56(2):365-71. PubMed ID: 16002421
[TBL] [Abstract][Full Text] [Related]
22. Non-typeable
Short B; Carson S; Devlin AC; Reihill JA; Crilly A; MacKay W; Ramage G; Williams C; Lundy FT; McGarvey LP; Thornbury KD; Martin SL
Crit Rev Microbiol; 2021 Mar; 47(2):192-205. PubMed ID: 33455514
[No Abstract] [Full Text] [Related]
23. Immunoglobulin A Protease Variants Facilitate Intracellular Survival in Epithelial Cells By Nontypeable Haemophilus influenzae That Persist in the Human Respiratory Tract in Chronic Obstructive Pulmonary Disease.
Murphy TF; Kirkham C; Gallo MC; Yang Y; Wilding GE; Pettigrew MM
J Infect Dis; 2017 Dec; 216(10):1295-1302. PubMed ID: 28968876
[TBL] [Abstract][Full Text] [Related]
24. Lung Surfactant Lipids Provide Immune Protection Against
García-Fojeda B; González-Carnicero Z; de Lorenzo A; Minutti CM; de Tapia L; Euba B; Iglesias-Ceacero A; Castillo-Lluva S; Garmendia J; Casals C
Front Immunol; 2019; 10():458. PubMed ID: 30936871
[TBL] [Abstract][Full Text] [Related]
25. Ampicillin resistance in
Maddi S; Kolsum U; Jackson S; Barraclough R; Maschera B; Simpson KD; Pascal TG; Durviaux S; Hessel EM; Singh D
Int J Chron Obstruct Pulmon Dis; 2017; 12():1507-1518. PubMed ID: 28579769
[TBL] [Abstract][Full Text] [Related]
26. Understanding nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease.
Alikhan MM; Lee FE
Curr Opin Pulm Med; 2014 Mar; 20(2):159-64. PubMed ID: 24441573
[TBL] [Abstract][Full Text] [Related]
27. Discovery and Contribution of Nontypeable Haemophilus influenzae NTHI1441 to Human Respiratory Epithelial Cell Invasion.
Ahearn CP; Kirkham C; Chaves LD; Kong Y; Pettigrew MM; Murphy TF
Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427451
[TBL] [Abstract][Full Text] [Related]
28. A clonal group of nontypeable Haemophilus influenzae with two IgA proteases is adapted to infection in chronic obstructive pulmonary disease.
Murphy TF; Lesse AJ; Kirkham C; Zhong H; Sethi S; Munson RS
PLoS One; 2011; 6(10):e25923. PubMed ID: 21998721
[TBL] [Abstract][Full Text] [Related]
29. Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis.
Roberts MC; Soge OO; No DB
J Antimicrob Chemother; 2011 Jan; 66(1):100-4. PubMed ID: 21081549
[TBL] [Abstract][Full Text] [Related]
30. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH
Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764
[TBL] [Abstract][Full Text] [Related]
31. Haemophilus influenzae in acute exacerbations of chronic obstructive pulmonary disease.
Leanord A; Williams C
Int J Antimicrob Agents; 2002 May; 19(5):371-5. PubMed ID: 12007844
[TBL] [Abstract][Full Text] [Related]
32. Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease.
Eldika N; Sethi S
Curr Opin Pulm Med; 2006 Mar; 12(2):118-24. PubMed ID: 16456381
[TBL] [Abstract][Full Text] [Related]
33. Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.
Ahearn CP; Gallo MC; Murphy TF
Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28449098
[TBL] [Abstract][Full Text] [Related]
34. Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters.
Wang D; Wang Y; Liu YN
Pulm Pharmacol Ther; 2010 Aug; 23(4):292-9. PubMed ID: 20211751
[TBL] [Abstract][Full Text] [Related]
35. Role of nontypeable Haemophilus influenzae in otitis media and chronic obstructive pulmonary disease.
Thanavala Y; Lugade AA
Adv Otorhinolaryngol; 2011; 72():170-5. PubMed ID: 21865721
[TBL] [Abstract][Full Text] [Related]
36. A chalcone with potent inhibiting activity against biofilm formation by nontypeable Haemophilus influenzae.
Kunthalert D; Baothong S; Khetkam P; Chokchaisiri S; Suksamrarn A
Microbiol Immunol; 2014 Oct; 58(10):581-9. PubMed ID: 25154700
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of the Thymidylate Synthase
Rodríguez-Arce I; Martí S; Euba B; Fernández-Calvet A; Moleres J; López-López N; Barberán M; Ramos-Vivas J; Tubau F; Losa C; Ardanuy C; Leiva J; Yuste JE; Garmendia J
Front Cell Infect Microbiol; 2017; 7():266. PubMed ID: 28676846
[TBL] [Abstract][Full Text] [Related]
38. Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo.
Babl FE; Pelton SI; Li Z
Antimicrob Agents Chemother; 2002 Jul; 46(7):2194-9. PubMed ID: 12069974
[TBL] [Abstract][Full Text] [Related]
39. Haemophilus influenzae and smoking-related obstructive airways disease.
Otczyk DC; Clancy RL; Cripps AW
Int J Chron Obstruct Pulmon Dis; 2011; 6():345-51. PubMed ID: 21760721
[TBL] [Abstract][Full Text] [Related]
40. Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae.
Finney LJ; Ritchie A; Pollard E; Johnston SL; Mallia P
Int J Chron Obstruct Pulmon Dis; 2014; 9():1119-32. PubMed ID: 25342897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
